Mode
Text Size
Log in / Sign up

Tricuspid Regurgitation

Part of Heart Valve Diseases

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Tricuspid Regurgitation

4 trials tracked for Tricuspid Regurgitation: 1 in phase 3 or 4.

4Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Other / NA 3
  1. Phase 3 Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER) Completed
  2. N/A Edwards CLASP TR EFS Completed
  3. N/A Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery Completed
  4. N/A TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Heart Valve Diseases

Related studies from across the Heart Valve Diseases family.

Questions about Tricuspid Regurgitation

Is autologous pericardial annuloplasty effective at reducing Tricuspid Regurgitation recurrence?

Autologous pericardial annuloplasty is associated with a significantly lower rate of moderate tricuspid regurgitation recurrence at 48 and 96 months compared to prosthetic ring annuloplasty in patients with rheumatic heart disease.

Full answer →